Bellevue Life Sciences Acquisition Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 103.6% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
36.2%	Bellevue Global Life Sciences Investors, LLC	2,035,000	US$21.8m	0%	no data
6.58%	BCM Europe AG	370,000	US$4.0m	-45.6%	no data
6.58%	Cowen Inc,Private Banking and Investment Banking Investments	369,852	US$4.0m	2,250%	0.13%
5.74%	WR Berkley Corp., Asset Management Arm	322,690	US$3.5m	0%	0.23%
5.18%	Wolverine Asset Management, LLC	291,505	US$3.1m	59.2%	0.29%
4.67%	Walleye Capital LLC	262,700	US$2.8m	0%	0.02%
4.62%	Polar Asset Management Partners Inc.	260,000	US$2.8m	0%	0.1%
4.45%	AQR Capital Management, LLC	249,995	US$2.7m	0%	no data
4.36%	RiverNorth Capital Management, LLC	245,115	US$2.6m	0%	0.13%
3.82%	Fir Tree Capital Management LP	214,860	US$2.3m	58.5%	1.01%
3.56%	Exos Asset Management LLC	200,000	US$2.1m	0%	1.3%
3.04%	Wealthspring Capital LLC	170,745	US$1.8m	-42.9%	0.46%
2.74%	Gritstone Asset Management LLC	154,268	US$1.7m	0%	2.92%
2.67%	Periscope Capital Inc.	150,000	US$1.6m	0%	0.47%
1.89%	Deltec Asset Management LLC	106,248	US$1.1m	0%	0.23%
1.78%	Aristeia Capital, LLC	100,000	US$1.1m	0%	0.08%
1.54%	Karpus Management Inc	86,650	US$929.8k	0%	0.03%
1.33%	Mint Tower Capital Management B.V.	75,000	US$804.8k	0%	0.9%
0.6%	K2 & Associates Investment Management Inc.	33,589	US$360.4k	0%	0.2%
0.48%	Warberg Asset Management LLC	27,040	US$290.1k	0%	1.45%
0.36%	Radclyffe Roberts	20,000	US$214.6k	0%	no data
0.36%	Steven Reed	20,000	US$214.6k	0%	no data
0.36%	David Yoo	20,000	US$214.6k	0%	no data
0.36%	In Chung	20,000	US$214.6k	0%	no data
0.36%	Jin Park	20,000	US$214.6k	0%	no data